Skip to main content
. 2016 Feb 25;8(3):175–180. doi: 10.1177/1756287216629870

Table 1.

Demographics.

Demographic Radium 223 (n = 58)
Age (years) median (range) 71 (54–84)
ECOG performance status
 0 18 (31%)
 1 35 (60%)
 2 5 (9%)
Number of cycles, median (range) 5 (1–6)
Previous lines of treatment, median (range) 3 (1–5)
Prior docetaxel (%)
 Yes 30 (52%)
 No 28 (48%)
Prior bisphosphonates, n (%)
 Yes 10 (17%)
 No 48 (83%)
Prior strontium, n (%)
 Yes 3 (5%)
 No 55 (95%)

ECOG, Eastern Cooperative Oncology Group.